Apple Inc. (AAPL), BioDelivery Sciences International Inc. (BDSI) Among Thomas Bailard’s Top Q2 Top Picks

Thomas Bailard is the co-founder and current manager of Bailard Inc. Located in California, Bailard uses quantitative and fundamental analyses to choose its investments. In its latest 13F filing, Bailard Inc. has disclosed a total of 235 positions as of the end of the second quarter of 2014. The value of the fund’s equity portfolio amounted to $650.1 million, up from $630.5 million reported as at the end of the previous quarter.

AAPL Apple Store

From the Bailard’s equity portfolio, we have picked top five holdings, in term of value. The first on the list is Apple Inc. (NASDAQ:AAPL), in which the fund boosted its position to 84,196 shares, worth $7.82 million, from 9,142 shares. For its fiscal 2014 third quarter ended June 28, 2014, Apple Inc. (NASDAQ:AAPL) reported revenue of $37.4 billion, compared to $35.3 billion in the year-ago quarter. Its quarterly net profit was $7.7 billion, or $1.28 per diluted share, compared to net profit of $6.9 billion, or $1.07 per diluted share, in the same quarter of 2013. Among other shareholders of Apple Inc. (NASDAQ:AAPL) include David Einhorn‘s Greenlight Capital and Natixis Global Asset Management‘s Harris Associates, holding 1.99 million shares and 1.56 million shares, respectively.

Bailard revealed upping its stake in BioDelivery Sciences International Inc. (NASDAQ:BDSI) to 398,000 shares, with a reported value of $4.80 million. Previously, the fund reported ownership of 342,400 shares of the company. BioDelivery Sciences International Inc. (NASDAQ:BDSI) is a specialty pharmaceutical company focusing in the areas of pain management and addiction medicine, has a market cap of $622.01 million. Aside from Bailard, Deerfield Management, led by James E. Flynn, owns 3.99 million shares of BioDelivery Sciences International Inc. (NASDAQ:BDSI) and Kevin Kotler’s Broadfin Capital holds 3.47 million shares.

The third position is held by Johnson & Johnson (NYSE:JNJ), in which the fund disclosed a $4.36 million stake, which contains 41,638 shares. The stake represents an increase from 39,373 the fund held previously. Recently, Johnson & Johnson (NYSE:JNJ), which is engaged in the research and development and sale of health care products, announced that its board of directors approved the repurchase of up to $5 billion of the company’s common stock. Other significant shareholders of Johnson & Johnson (NYSE:JNJ) include Ken Fisher’s Fisher Asset Management, owning 9.98 million shares, and Donald Yacktman’s Yacktman Asset Management, holding 9.57 million shares of the company.

In Chevron Corporation (NYSE:CVX), Bailard disclosed holding 30,575 shares, with a reported value of $3.99 million. The stake is up from 29,138 the fund held earlier. Chevron Corporation (NYSE:CVX) is an integrated energy company having a market cap of $248.60 billion. Last month, the company’s subsidiary Chevron Global Energy Inc. announced the sale of its 25% non-operated interest in a producing oil concession in southern Chad and the related export pipeline interests to the Republic of Chad for about $1.3 billion. In addition to Bailard, other shareholders of the company include Ken Fisher’s Fisher Asset Management, owning 3.50 million shares, according to our record. Another investor, Adage Capital Management, managed by Phill Gross and Robert Atchinson, revealed owning 2.73 million shares of Chevron Corporation (NYSE:CVX).

On the fifth spot is Enanta Pharmaceuticals Inc. (NASDAQ:ENTA), in which the fund increased its position to 91,500 shares, worth $3.94 million, from 74,306 shares. Enanta Pharmaceuticals Inc. (NASDAQ:ENTA) is a research and development-focused biotechnology company. For the fiscal second quarter ended March 31, 2014, the company reported revenue of $2.2 million, compared to $1.2 million for the same period of 2013. It reported a net loss of $5.2 million, compared to a net loss of $3.7 million for the same quarter last year. The shareholders of the company, in addition to Bailard, include Peter Kolchinsky’s RA Capital Management and Mitchell Blutt’s Consonance Capital Management, holding 1.54 million and 1.25 million shares of the company, respectively.

Disclosure: none

Biotech Insider Alert - $6 Stock To Hit $40

$200 Million Dollar Healthcare Hedge Fund's #1 Best Idea Right Now

The best healthcare hedge fund out there right now is one of the largest shareholders in this biotech stock. The fund returned more than 20% in each of the last 2 years with a virtually fully hedged portfolio, and it's sending out a BUY signal on this biotech stock. Get your FREE REPORT today (retail value of $300)

This is a FREE report from Insider Monkey. Credit Card is NOT required.
Comments
Insider Monkey Small Cap Strategy
Insider Monkey Small Cap Strategy

Insider Monkey beat the market by 52 percentage points in 24 months. Our beta is only 1.2 (don't click this link if beating the market isn't important to you).

Lists

The Most Wanted Drug Lords

The Oldest Money Managers

The Greatest Directors in the World

Largest Animals in the World

World’s Most Expensive Desserts

Best Selling Comic Books of All Time

A-list Actors who Sabotaged Their Career

Rappers With a College Degree

The Best Jazz Albums of all Time

The Most Influential Jazz Musicians

The World’s Most Famous Photographers

The Best Oscar-Winning Songs

Most Influential Choreographers Ever

Most Expensive Department Stores in the World

The Most Expensive Stolen Paintings in the World

The World’s Most Expensive Teas

Top Oscar Record Holders

The Most Expensive Flowers in the World

Countries With a Booming Film Industry

Most Expensive Cupcakes in the World

Uncommon European Escapes

The Most Stolen Artists in History

Best Travel Destinations in Australia

World’s Most Expensive Musical Instruments

World’s Most Famous Animals

Most Expensive Cakes in the World

Most Expensive Kosher Champagne in the World

Most Expensive Kosher Wine in the World

The Most Surprisingly Dark Fairy Tales

Most Popular Travel Destinations in Asia

The 10 Most Expensive Dresses Ever Worn to the Oscars

World’s Most Visited Art Museums

Best Countries for Photographers to Work in

Best Paid Jobs in the Film Industry

The Most Renowned Recovered Paintings Ever

Child Stars That Turned out Just Fine

Books That Were Banned in the Past Century

World’s Richest Dancers

Best Remedies against Bad Breath

Foods That Improve Your Skin Texture

Best-Selling Children’s Books of all Time

Foods That Boost Your Libido

Best-Selling Books of all Time

The Most Expensive Academy Awards Jewelry in History

Most Expensive Japanese Restaurant In New York City

The Best B-Boy Movies

Most Awesome Hip Hop Documentaries

Foods That Stain Your Teeth

Richest Doctors in the World

The Best Movie Sountracks Ever

Subscribe

Enter your email:

Delivered by FeedBurner

X

Thanks! An email with instructions is sent to !

Your email already exists in our database. Click here to go to your subscriptions

Insider Monkey returned 129% in 2.5 years!! Wondering How?

Download a complete edition of our newsletter for free!